[Metabolic anomalies in bone metastasis of cancer].
Chuman
Hirokazu
H
National Cancer Center Hospital, Orthopaedic Division.
Nakatani
Fumihiko
F
D015415:Biomarkers / Q000032:analysis; D050071:Bone Density Conservation Agents / Q000008:administration & dosage; D001851:Bone Diseases, Metabolic / Q000175:diagnosis / Q000209:etiology* / Q000378:metabolism / Q000628:therapy; D001859:Bone Neoplasms / Q000556:secondary* / Q000628:therapy; D016723:Bone Remodeling; D024042:Collagen Type I / Q000032:analysis; D003952:Diagnostic Imaging; D004164:Diphosphonates / Q000008:administration & dosage; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology / Q000628:therapy; D010455:Peptides / Q000032:analysis
D015415:Biomarkers; D050071:Bone Density Conservation Agents; D024042:Collagen Type I; D004164:Diphosphonates; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide